With Technology to Fight the Growing Burden of Chronic Liver Disease

Get an inside look at in-depth discussions with physicians and administrators at some of the nation’s leading Federally Qualified Health Centers (FQHCs). Featuring multiple centers with unique problems, this paper describes successful approaches for the early identification of liver disease –a silent epidemic affecting millions of Americans as the rates of obesity and diabetes continue to accelerate.

The paper demonstrates through real-world case studies how FQHCs, community-based health care providers that receive funds from the Health Resources and Services Administration (HRSA) Health Center Program, are acquiring FibroScan® technology, a painless five-minute screening, as part of an overall workup to help diagnose NAFLD early on. This non-invasive test quickly provides a quantitative assessment of liver stiffness and fat at the point of care. With over 2,000 peer-reviewed research publications, FibroScan technology is the most widely studied tool for point-of-care liver assessment.

The case studies outlined in this paper, illustrate how FibroScan is empowering FQHCs to deliver an on-site, comprehensive service–and serving as a key strategy for hepatitis C care.

 

Download White Paper